Barriers to Lung Cancer Screening Engagement from the Patient and Provider Perspective

被引:138
作者
Wang, Gary X. [1 ]
Baggett, Travis P. [2 ,6 ]
Pandharipande, Pari V. [1 ,4 ]
Park, Elyse R. [3 ,5 ,6 ]
Percac-Lima, Sanja [2 ]
Shepard, Jo-Anne O. [1 ]
Fintelmann, Florian J. [1 ]
Flores, Efren J. [1 ]
机构
[1] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, 55 Fruit St,Founders 202, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, Div Gen Internal Med, 55 Fruit St,Founders 202, Boston, MA 02114 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, 55 Fruit St,Founders 202, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Mongan Inst Hlth Policy Ctr, Boston, MA 02114 USA
[6] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA
关键词
DOSE COMPUTED-TOMOGRAPHY; SHARED DECISION-MAKING; PRIMARY-CARE PROVIDERS; HIGH-RISK; COLORECTAL CANCERS; CHEST PHYSICIANS; ATTITUDES; COMMUNITY; CT; IMPLEMENTATION;
D O I
10.1148/radiol.2018180212
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Lung cancer remains the leading cause of cancer mortality in the United States. Lung cancer screening (LCS) with low-dose CT reduces mortality among high-risk current and former smokers and has been covered by public and private insurers without cost sharing since 2015. Patients and referring providers confront numerous barriers to participation in screening. To best serve in multidisciplinary efforts to expand LCS nationwide, radiologists must be knowledgeable of these challenges. A better understanding of the difficulties confronted by other stakeholders will help radiologists continue to collaboratively guide the growth of LCS programs in their communities. This article reviews barriers to participation in LCS for patients and referring providers, as well as possible solutions and interventions currently underway. (c) RSNA, 2019
引用
收藏
页码:278 / 287
页数:10
相关论文
共 88 条
  • [1] Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
    Aberle, Denise R.
    Adams, Amanda M.
    Berg, Christine D.
    Black, William C.
    Clapp, Jonathan D.
    Fagerstrom, Richard M.
    Gareen, Ilana F.
    Gatsonis, Constantine
    Marcus, Pamela M.
    Sicks, JoRean D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (05) : 395 - 409
  • [2] Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial
    Ali, Noor
    Lifford, Kate J.
    Carter, Ben
    McRonald, Fiona
    Yadegarfar, Ghasem
    Baldwin, David R.
    Weller, David
    Hansell, David M.
    Duffy, Stephen W.
    Field, John K.
    Brain, Kate
    [J]. BMJ OPEN, 2015, 5 (07):
  • [3] American Association of Family Physicians, CLIN PREV SERV REC L
  • [4] American College of Radiology, CY 2018 OPPS FIN RUL
  • [5] American College of Radiology, LUNG CANC SCREEN RES
  • [6] [Anonymous], LUNG CANC SCREEN TOO
  • [7] [Anonymous], NAT RAD DAT REG
  • [8] [Anonymous], LUNG CT SCREEN REP D
  • [9] [Anonymous], The American Lung Association Interim Report on Lung Cancer Screening
  • [10] Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs
    Armstrong, Katrina
    Kim, Jane J.
    Halm, Ethan A.
    Ballard, Rachel M.
    Schnall, Mitchell D.
    [J]. CANCER, 2016, 122 (09) : 1338 - 1342